UBS Launches New ETN Linked to the Solactive Whitney U.S. Critical Technologies CNTR Index
March 31 2023 - 4:00PM
Business Wire
UBS Investment Bank today announced the recent listing of a new
ETN linked to the Solactive Whitney U.S. Critical Technologies CNTR
Index, which is specified in the table below.
ETN
Ticker
ETN Name
ETN CUSIP
Underlying Index
Bloomberg Ticker
WUCT
ETRACS Whitney US Critical Technologies
ETN
90278V222
SOLUCTIC
About the Solactive Whitney U.S. Critical Technologies CNTR
Index
The Solactive Whitney U.S. Critical Technologies CNTR Index (the
“Index”) is a market-capitalization weighted index, subject to caps
on individual companies, that is designed to track large- and
mid-cap companies that are associated with critical technology
sectors and that meet a minimum “geostrategic risk rating score”.
The index universe is derived from large and mid-cap companies in
developed market countries included in the Solactive GBS Developed
Markets Large & Mid Cap USD Index. Companies from the index
universe are eligible for inclusion in the Index if (i) they are
associated with one of the 14 critical technology sectors and (ii)
they receive a sufficiently high geostrategic risk rating score,
each as determined pursuant to the Index selection criteria. The
Index is an adjusted net total return index and the Index level
reflects the notional reinvestment of the cash distributions from
its constituent securities, subject to dividend withholding taxes,
on distributions made by applicable non-U.S. Index constituent
securities. No dividend withholding taxes are applied to
distributions made by applicable U.S. Index constituent securities.
The Index was first disseminated publicly on January 3, 2023 and
has no live history prior to that date.
About ETRACS
ETRACS ETNs are senior unsecured notes issued by UBS AG, are
traded on NYSE Arca, and can be bought and sold through a broker or
financial advisor. An investment in ETRACS ETNs is subject to a
number of risks, including the risk of loss of some or all of the
investor’s principal, and is subject to the creditworthiness of UBS
AG. Investors are not guaranteed any coupon or distribution amount
under the ETNs. We urge you to read the more detailed
explanation of risks described under “Risk Factors” in the
applicable prospectus supplement for the ETRACS ETN.
UBS AG has filed a registration statement (including a
prospectus and supplements thereto) with the Securities and
Exchange Commission, or SEC, for the offerings of securities to
which this communication relates. Before you invest, you should
read the prospectus, along with the applicable prospectus
supplement to understand fully the terms of the securities and
other considerations that are important in making a decision about
investing in the ETRACS. The applicable offering document for each
ETRACS may be obtained by clicking on the name of each ETRACS
identified above. You may also get these documents without cost by
visiting EDGAR on the SEC website at www.sec.gov. The securities
related to the offerings are not deposit liabilities and are not
insured or guaranteed by the Federal Deposit Insurance Corporation
or any other governmental agency of the United States, Switzerland
or any other jurisdiction.
About UBS
UBS convenes the global ecosystem for investing, where people
and ideas are connected and opportunities brought to life, and
provides financial advice and solutions to wealthy, institutional
and corporate clients worldwide, as well as to private clients in
Switzerland. UBS offers investment solutions, products and
impactful thought leadership, is the leading global wealth manager,
provides large-scale and diversified asset management, focused
investment banking capabilities, and personal and corporate banking
services in Switzerland. The firm focuses on businesses that have a
strong competitive position in their target markets, are capital
efficient and have an attractive long-term structural growth or
profitability outlook.
UBS is present in all major financial centers worldwide. It has
offices in more than 50 regions and locations, with about 30% of
its employees working in the Americas, 30% in Switzerland, 19% in
the rest of Europe, the Middle East and Africa and 21% in Asia
Pacific. UBS Group AG employs more than 72,000 people around the
world. Its shares are listed on the SIX Swiss Exchange and the New
York Stock Exchange (NYSE).
This material is issued by UBS AG and/or any of its subsidiaries
and/or any of its affiliates ("UBS"). Products and services
mentioned in this material may not be available for residents of
certain jurisdictions. Past performance is not necessarily
indicative of future results. Please consult the restrictions
relating to the product or service in question for further
information. Activities with respect to US securities are conducted
through UBS Securities LLC, a US broker/dealer. Member of SIPC
(http://www.sipc.org/).
ETRACS ETNs are sold only in conjunction with the relevant
offering materials. UBS has filed a registration statement
(including a prospectus, as supplemented by the applicable
prospectus supplement, for the offering of the ETRACS ETNs) with
the Securities and Exchange Commission (the “SEC”) for the offering
to which this communication relates. Before you invest, you should
read these documents and any other documents that UBS has filed
with the SEC for more complete information about UBS and the
offering to which this communication relates. You may get these
documents for free by visiting EDGAR on the SEC website at
www.sec.gov. Alternatively, you can request the prospectus and
applicable prospectus supplement by calling toll-free (+1-877-387
2275). In the US, securities underwriting, trading and brokerage
activities and M&A advisor activities are provided by UBS
Securities LLC, a registered broker/dealer that is a wholly owned
subsidiary of UBS AG, a member of the New York Stock Exchange and
other principal exchanges, and a member of SIPC. UBS Financial
Services Inc. is a registered broker/dealer and affiliate of UBS
Securities LLC.
Solactive AG (“Solactive”) is the licensor of Solactive Whitney
U.S. Critical Technologies CNTR Index (the “Index”). The Index has
been developed in cooperation with J.H. Whitney Data Services, LLC
(“J.H. Whitney”). The financial instruments that are based on the
Index are not sponsored, endorsed, promoted or sold by Solactive or
J.H. Whitney in any way and Solactive or J.H. Whitney make no
express or implied representation, guarantee or assurance with
regard to: (a) the advisability of investing in the financial
instruments; (b) the quality, accuracy and/or completeness of the
Index; and/or (c) the results obtained or to be obtained by any
person or entity from the use of the Index. Solactive or J.H.
Whitney do not guarantee the accuracy and/or the completeness of
the Index and shall not have any liability for any errors or
omissions with respect thereto. The Index has not been designed to
achieve positive returns and neither Solactive nor J.H. Whitney is
acting as a fiduciary or investment adviser for any user of the
Index or investor in any financial instrument based on the Index.
Notwithstanding Solactive’s obligations to its licensees, Solactive
reserves the right to change the methods of calculation or
publication with respect to the Index and Solactive or J.H. Whitney
shall not be liable for any miscalculation of or any incorrect,
delayed or interrupted publication with respect to the Index.
Solactive or J.H. Whitney shall not be liable for any damages,
including, without limitation, any loss of profits or business, or
any special, incidental, punitive, indirect or consequential
damages suffered or incurred as a result of the use of (or
inability to use) the Index.
UBS specifically prohibits the redistribution or reproduction of
this communication in whole or in part without the prior written
permission of UBS and UBS accepts no liability whatsoever for the
actions of third parties in this respect.
© UBS 2023. The key symbol, UBS and ETRACS are among the
registered and unregistered trademarks of UBS. Other marks may be
trademarks of their respective owners. All rights reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230331005403/en/
Media contact Alison Keunen 1-212-713-2296
alison.keunen@ubs.com
Institutional Investor contact1 +1-877-387 2275
____________________ 1 Individual investors should instruct
their broker/advisor/custodian to call us or should call together
with their broker/advisor/custodian.
UBS (NYSE:UBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
UBS (NYSE:UBS)
Historical Stock Chart
From Apr 2023 to Apr 2024